Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v12-EN
Language English English
Date Updated 2022-08-25 2022-08-24
Drug Identification Number 02516322 02516322
Brand name TEPMETKO TEPMETKO
Common or Proper name tepotinib tablets tepotinib tablets
Company Name EMD SERONO, A DIVISION OF EMD INC., CANADA EMD SERONO, A DIVISION OF EMD INC., CANADA
Ingredients
Strength(s) 225MG 225MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 60 tablets 60 tablets
ATC code L01EX L01EX
ATC description
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-08-05 2022-08-05
Actual start date 2022-08-05 2022-08-05
Estimated end date 2022-09-09 2022-09-09
Actual end date 2022-08-24 2022-08-24
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments